Top Markets
#1 Wiki Cat Wiki Cat +42.56%
#2 Siren Siren +36.06%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.29%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.07%
#5 PulseChain PulseChain +17.52%
#6 Velvet Velvet +17.46%
#7 KUB Coin KUB Coin +17.22%
#8 aPriori aPriori +16.23%
#9 Cysic Cysic +15.45%
#10 OpenEden OpenEden +15.08%
Coin of the day
Wiki Cat Wiki Cat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Classement en actions #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Prix de l'action
$0.01084256
Capitalisation boursière
$13.87M
Changement (1 jour)
0.00%
Changement (1 an)
1.70%
Pays
NZ
Échange BLIS Technologies Limited (BLT)

Catégorie

Healthcare
Bénéfices pour BLIS Technologies Limited (BLT)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de BLIS Technologies Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour BLIS Technologies Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE